ABSTRACT OBJECTIVES This study assessed potential improvement in predicting risk of sudden cardiac death (SCD) by adding selected risk markers from the 12-lead electrocardiogram (ECG) to the measurement of left ventricular ejection fraction (LVEF).
D
espite concerted efforts in the field of resuscitation over the past few decades, out-of-hospital sudden cardiac arrest is fatal in a majority of individuals (>90%) within the first few minutes of the event (1) . Therefore, efforts at prediction and prevention of sudden cardiac death (SCD) remain vital. Although the implantable cardioverter-defibrillator (ICD) is an effective intervention to reduce arrhythmic mortality (2, 3) , the challenge lies in identifying the high-risk individual who will optimally benefit from it due to concerns of cost as well as potential harm (4) . Left ventricular (LV) systolic dysfunction, which has been used almost exclusively as the clinical predictor of SCD risk, lacks adequate discriminating power, highlighting the need for alternative approaches to risk stratification (5) .
Although several other risk markers have been evaluated (6) (7) (8) (9) , they await incorporation into improved risk stratification algorithms. One of the statistical challenges in identifying effective novel markers is that high odds ratios (ORs) are required to improve risk prediction at the individual level (10), almost never achievable by single markers. Combining multiple risk markers to additively improve risk may therefore represent the next logical step in improving SCD risk prediction (5, 11) . Ideally, such markers should be derived from widely available, preferably inexpensive clinical tools.
Prospective cohort studies are a robust setting for the evaluation of risk predictors. However, given the low annual incidence of SCD in the population, very large cohorts are needed to obtain adequate numbers, which poses practical challenges. Community-based case-control studies with prospective ascertainment of SCD offer the advantage of being able to obtain feasible numbers for analysis within a reasonable time and therefore can be a valuable complementary approach to cohort studies (12) . Although previous studies have evaluated the concept of using multiple markers to enhance SCD risk prediction (13) (14) (15) (16) , there are a lack of studies in the general population. From the Oregon-SUDS (Oregon Sudden Unexpected Death Study), we have previously reported on the utility of certain parameters from 12-lead electrocardiography (ECG) that could represent simple, noninvasive markers that enhance stratification of SCD risk (17) (18) (19) . However, we have not previously evaluated a combination of these ECG markers together. Therefore, in the present study, we tested the hypothesis that combining multiple select risk markers from the surface ECG could have cumulative effects on the risk of SCD and improve the risk prediction model beyond LV ejection fraction (LVEF).
METHODS
CASE ASCERTAINMENT. Subjects with SCD were identified from the ongoing Oregon-SUDS, a community-based study of SCD in the Portland, Oregon, metropolitan region (population w1 million).
Methods were previously published (20, 21) . Briefly, individuals of any age who experienced out-ofhospital sudden cardiac arrest were identified through collaboration with the region's emergency medical response system, the Medical Examiner's office, and local hospitals. Cardiac arrests were adjudicated and included in the study as SCD only after comprehensive review of the arrest circumstances as recorded by the emergency medical response system team, the patient's medical history prior to the SCD, and autopsy data, if available. If they met criteria, survivors of cardiac arrest were included as SCD cases. SCD was defined as a sudden unexpected pulseless condition likely of cardiac origin, occurring after a rapid witnessed collapse; unwitnessed deaths occurring within 24 hours of the patient being seen alive in a normal state of health were also included (22) . Subjects were excluded if they had a prior terminal illness (e.g., terminal cancer) or any identifiable noncardiac cause of sudden death, such as stroke, pulmonary embolism, trauma, violent death, overdose, drowning, or suicide.
Although patients with a history of congestive heart failure were included in the case population, the adjudication process maximized the likelihood the cardiac arrest cases with rapid, unexpected collapse and likely cardiac cause were included. Patients in hospice or those with end-stage heart failure with progressive deterioration in the days preceding arrest were excluded. 2) patients who visited the cardiology clinic or who had angiography (with $50% stenosis noted on a coronary artery) at 1 of the participating hospitals; and 3) members of the region's Kaiser Permanente health maintenance organization. Medical records were retrieved and reviewed for all potential control subjects to determine whether the patient had a history of CAD.
Control subjects were enrolled if they provided consent and were found to have documented CAD based on available medical records, as defined below, and no history of ventricular arrhythmia. 
Reinier et al. Heart rate and QRS duration were read by computer; JT, QT, and RR intervals were manually read using into a "low-risk" group if all 3 ECG markers were below the median; or a moderate risk ECG marker group (if at least 1 ECG marker was above the median value, but at most 1 ECG marker was above the 75th percentile). We evaluated model fit with the HosmerLemeshow goodness of fit test (25) and model discrimination with the C statistic (26) . We calculated the sensitivity and specificity of models with and without ECG markers by using the classification table output from SAS PROC LOGISTIC feature (SAS, Cary, North Carolina), using a predicted probability of $0.5 to indicate high risk. Furthermore, we calculated net reclassification improvement and integrated discrimination improvement, comparing the models with and without ECG variables (27) . We interpreted significant improvement in C statistic with the addition of ECG markers to indicate improved prediction of SCD. Likewise, if the net reclassification 
RESULTS
UNIVARIATE RESULTS. Among the 317 cases and 317 controls ( Table 1) , cases were more likely to have diabetes (50% vs. 31%, respectively; p < 0.0001) and lower EF (49% vs. 56%, respectively; p < 0.0001).
Cases also had significantly elevated ECG markers (p < 0.0001), with a heart rate 9 beats/min faster than that of controls (77 vs. 68 beats/min, respectively), a longer QRS duration (106 vs. 99 ms, respectively), a prolonged JTc interval (351 vs. 335 ms, respectively), and QTc interval (458 vs. 428 ms, respectively).
Severely reduced LV systolic function (EF #35%) was much more common among cases (26% vs. 11%, respectively), whereas ECG markers at or above the 75th percentile were observed in a significantly higher proportion of cases (p # 0.002, Table 1 ).
CUMULATIVE EFFECT OF ECG MARKERS.
In multivariate modeling, EF of #35% was associated with 2.8-fold increased odds of SCD ( percentile) was also significantly associated with SCD (heart rate OR: 2.6; 95% CI: 1.8 to 3.7; JTc interval OR: 2.3; 95% CI: 1.6 to 3.4; and QRS duration OR: 1.5; 95% CI: 1.0 to 2.5). We tested for potential interactions between beta-blockers and EF, heart rate, QRS, and Using a predicted probability of 0.50 as the cutoff to identify high-risk patients, we determined the model with only EF had a sensitivity of 60.6% and a specificity of 62.5%, whereas the EF plus ECG model had a sensitivity of 63.1% and a specificity of 69.4%.
Use of a predicted probability cutoff of 0.40 in the full model resulted in a sensitivity of $80%, whereas a cutoff of 0.60 resulted in a specificity of $80%.
In analyses, when EF and ECG markers were modeled as continuous variables, results were similar; EF and each ECG marker were significantly associated with SCD (p # 0.002), and the C statistic Values are mean AE SD or n (%). *Case and control subjects matched on age (5-year categories) and sex. †For QTc, n ¼ 240 cases, n ¼ 267 controls. QTc was not calculated for subjects with QRS <120, according to convention. ‡Cut points $75th percentile in controls are shown in parentheses.
EF ¼ ejection fraction; MI ¼ myocardial infarction; SUDS ¼ Sudden Unexpected Death Study. Abbreviations are as shown in Table 1 .
Reinier et al. When we examined the cumulative joint effects of the ECG markers ( Table 4 shows a reclassification table (27) for the adjusted logistic regression models with and without ECG markers, modeled as in approach 1) described in show that a combination of these markers has a cumulative effect and could identify individuals at even higher risk than that conferred by a single marker. Using a matched population of SCD cases and CAD controls, we confirmed the independent predictive ability of these selected ECG risk markers. Each marker (heart rate, JTc, and QRSD), modeled independently and adjusting for EF and clinical characteristics, was associated with increased odds of SCD.
Next, we demonstrated that consideration of multiple markers together result in much higher odds for SCD (more than 6-fold higher with 2 abnormally high markers) compared with the presence of a single marker, which suggests that using several markers may additively improve SCD risk prediction. (14) . An interesting finding from this study was that patients with only low LVEF as a risk predictor may be at relatively lower risk of mortality Values are n or n (%). Net reclassification improvement ¼ 22.7%, z ¼ 4.811, p < 0.0001. Values in bold indicate an improvement in prediction of SCD with addition of ECG markers (movement from lower to higher predicted probability for cases, and from higher to lower predicted probability for controls). Values in italics indicate worsening prediction (movement from higher to lower predicted probability for cases, and from lower to higher predicted probability for controls). *Logistic model included the following terms: EF #35% vs. >35%, age, sex, diabetes, and hypertension. In the model with ECG markers, each marker (heart rate, JTc, and QRS) was entered separately as a dichotomous variable ($75th vs. <75th percentile). †Predicted probabilities from the logistic regression model. Note that when the predicted probability is 0.5, then the 2 outcomes (SCD or no SCD) are equally likely. Because SCD is not a single disease condition but rather the end result of the interaction of multiple deleterious processes, it stands to reason that strategies for prevention will need to rely on cumulative information from many risk markers, potentially reflecting different aspects of the disease process (33) . Future studies assessing other potentially relevant ECG markers will be needed. Although we looked at markers at a single point in time, risk is a dynamic phenomenon subject to temporal change, and more studies will be needed to address this aspect. Prior to clinical application with a view to improving primary prevention, the specificity of any risk prediction model for SCD (as opposed to nonsudden death) will need to be evaluated; however, we looked at markers to identify the best set of high-yield markers to improve SCA risk stratification.
CONCLUSIONS
The combined use of selected ECG risk variables, namely, resting heart rate, QRS duration, and JTc interval, resulted in improved SCD risk prediction when combined with low LVEF. These findings provide proof of concept for SCD cumulative risk prediction as well as a specific set of widely available and easily measured
ECG markers that could be tested in prospective cohort studies. 
